Co-Diagnostics CODX Stock
Co-Diagnostics Price Chart
Co-Diagnostics CODX Financial and Trading Overview
| Co-Diagnostics stock price | 0.26 USD |
| Previous Close | 0.27 USD |
| Open | 0.27 USD |
| Bid | 0.31 USD x 200 |
| Ask | 13.6 USD x 100 |
| Day's Range | 0.25 - 0.27 USD |
| 52 Week Range | 0.25 - 13.54 USD |
| Volume | 591.94K USD |
| Avg. Volume | 1.99M USD |
| Market Cap | 2.72M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -21.71 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4 USD |
CODX Valuation Measures
| Enterprise Value | 3.57M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.31156626 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.1650832 |
| Price/Book (mrq) | 0.2 |
| Enterprise Value/Revenue | 4.154 |
| Enterprise Value/EBITDA | -0.126 |
Trading Information
Co-Diagnostics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -97.26% |
| S&P500 52-Week Change | 13.32% |
| 52 Week High | 13.54 USD |
| 52 Week Low | 0.25 USD |
| 50-Day Moving Average | 0.8 USD |
| 200-Day Moving Average | 2.07 USD |
CODX Share Statistics
| Avg. Volume (3 month) | 1.99M USD |
| Avg. Daily Volume (10-Days) | 10.77M USD |
| Shares Outstanding | 10.51M |
| Float | 10.33M |
| Short Ratio | 2.21 |
| % Held by Insiders | 7.02% |
| % Held by Institutions | 6.15% |
| Shares Short | 981.33K |
| Short % of Float | 11.27% |
| Short % of Shares Outstanding | 11.11% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3415.84% |
| Gross Margin | 20.26% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -63.74% |
| Return on Equity (ttm) | -192.78% |
Income Statement
| Revenue (ttm) | 858.89K USD |
| Revenue Per Share (ttm) | 0.23 USD |
| Quarterly Revenue Growth (yoy) | 94.59% |
| Gross Profit (ttm) | 174.08K USD |
| EBITDA | -28391114 USD |
| Net Income Avi to Common (ttm) | -47475956 USD |
| Diluted EPS (ttm) | -21.71 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 714.8K USD |
| Total Cash Per Share (mrq) | 0.07 USD |
| Total Debt (mrq) | 1.56M USD |
| Total Debt/Equity (mrq) | 16.6 USD |
| Current Ratio (mrq) | 0.772 |
| Book Value Per Share (mrq) | 1.293 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26882600 USD |
| Levered Free Cash Flow (ttm) | -15207230 USD |
Profile of Co-Diagnostics
| Country | United States |
| State | UT |
| City | Salt Lake City |
| Address | 2401 S. Foothill Drive |
| ZIP | 84109 |
| Phone | 801 438 1036 |
| Website | https://co-dx.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 115 |
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
Q&A For Co-Diagnostics Stock
What is a current CODX stock price?
Co-Diagnostics CODX stock price today per share is 0.26 USD.
How to purchase Co-Diagnostics stock?
You can buy CODX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Co-Diagnostics?
The stock symbol or ticker of Co-Diagnostics is CODX.
Which industry does the Co-Diagnostics company belong to?
The Co-Diagnostics industry is Medical Devices.
How many shares does Co-Diagnostics have in circulation?
The max supply of Co-Diagnostics shares is 10.51M.
What is Co-Diagnostics Price to Earnings Ratio (PE Ratio)?
Co-Diagnostics PE Ratio is now.
What was Co-Diagnostics earnings per share over the trailing 12 months (TTM)?
Co-Diagnostics EPS is -21.71 USD over the trailing 12 months.
Which sector does the Co-Diagnostics company belong to?
The Co-Diagnostics sector is Healthcare.
Co-Diagnostics CODX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
|
- | |||||
US Tech Composite
IXIC
US
|
25136.27 USD — |
-0.91
|
7.74B USD — | 24872.41 USD — | 25423.09 USD — | — - | 7.74B USD — |
US Tech Capital Market Composite
RCMP
US
|
113.05 USD — |
-1.08
|
— — | 111.72 USD — | 114.38 USD — | — - | — — |
US Tech Health Care
IXHC
US
|
1368.29 USD — |
-0.34
|
— — | 1358.68 USD — | 1373.65 USD — | — - | — — |


